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Abstract
Background: Gram-negative microorganisms are uncommon pathogens responsible for infective endocarditis.
Pseudomonas mendocina, a Gram-negative water-borne and soil-borne bacterium, was first reported to cause
human infection in 1992. Since then, it has rarely been reported as a human pathogen in the literature. We
describe the first case of native valve infective endocarditis due to P. mendocina in the USA.
Case presentation: A 57-year-old white man presented with bilateral large leg ulcers, fever, and marked
leukocytosis. His past medical history included gout and chronic alcohol use. P. mendocina was isolated from
his blood cultures. A comprehensive review of P. mendocina infection in the literature was performed. A total
of eight cases of P. mendocina infection were reported in the literature. More than two-thirds of the cases of
P. mendocina septicemia were associated with native valve infective endocarditis. Thus, an echocardiogram was
performed and demonstrated mitral valve endocarditis with mild mitral insufficiency. His leg wounds were
debrided and were probably the source of P. mendocina bacteremia. Unlike Pseudomonas aeruginosa,
P. mendocina is susceptible to third-generation cephalosporins. Our patient received a 6-week course of
antimicrobial therapy with a favorable clinical outcome.
Conclusions: Our reported case and literature review illuminates a rare bacterial cause of infective endocarditis
secondary to P. mendocina pathogen. Native cardiac valves were affected in all reported cases of infective
endocarditis, and a majority of affected heart valves were left-sided. The antibiotics active against P.
mendocina are different from those that are active against P. aeruginosa, and they notably include third-
generation cephalosporins. The outcome of all reported cases of P. mendocina was favorable and no mortality
was described.
Keywords: Pseudomonas mendocina infection, Pseudomonas mendocina septicemia, Endocarditis,
Background
Infective endocarditis is a life-threatening infection of
the endocardial surfaces of the cardiac valves. Gram-
positive cocci, mainly Staphylococcus aureus and
Streptococci, are the leading causes of infective
endocarditis. Gram-negative rods and fungi are not
common pathogens of infective endocarditis [1].
Pseudomonas mendocina causing infective endocarditis
has rarely been reported in the literature. P. mendocina is
a ubiquitous soil and water dwelling Gram-negative non-
fermentative rod discovered in 1970 in Mendoza,
Argentina [2]. For the first 22 years after its discov-
ery, it was presumed to be non-pathogenic in
humans. As a soil and water organism, the primary
research into this organism looked at its abilities to
remediate oils and organic chemicals. Little to no
research was done into its pathogenicity or virulence
factors. In 1992, the first case of infection in humans
by P. mendocina was reported in Argentina in a
63-year-old man with infective endocarditis [3].
Here we present the first case of infective endocarditis
from P. mendocina reported in the USA and perform a
comprehensive review of the published literature of the
infection.
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Case presentation
A 57-year-old white man presented to our institution
with chief complaints of leg pain and a “rash” on his legs
that he believed was a flare of his chronic and recurrent
gout. He described severe leg pain, drainage of fluid
from his leg wounds (Figs. 1 and 2), and difficulty walk-
ing. He could not recall trauma or injury to his legs. He
denied any fever, but complained of some chills. The
worsening of the drainage of his leg wound was what
prompted him to seek help in an emergency room. His
only known past medical history was gout. His social
history was significant for at least six alcoholic drinks
per day. He denied illicit drug use.
On physical examination, he was awake and oriented to
time, place, and self. He was, however, in distress from his
leg pain. His vital signs revealed a temperature of 36.6 °C
(97.9 °F), heart rate of 90/minute, blood pressure of 172/96
mmHg, and respiratory rate of 16/minute with an oxygen
saturation of 100 % on room air. The other remarkable
physical findings included a gallop heart rhythm without
heart murmurs, and jugular venous distention. There were
two large cutaneous ulcerations over both his lower
legs. On his right shin, the lesion measured approxi-
mately 25×8 cm. The wound on his left ankle was
oval in shape and measured 8 cm in diameter (Figs. 1
and 2). Foul-smelling purulent drainage was noted on
his right shin ulcer. Laboratory studies showed a
marked leukocytosis of 24,000/mm3. X-rays of his
tibia and fibula showed soft tissue edema, but no discreet
osseous abnormalities. Blood cultures were drawn on
admission due to leukocytosis and the extensive nature of
the leg ulcerations. It was followed by empiric therapy
with intravenous vancomycin and piperacillin-tazobactam.
During admission, he became febrile with a
temperature of 38.5 °C (101.3 °F). A new systolic
heart murmur (3/6 intensity) at the cardiac apex was
noted on auscultation. Both sets of blood cultures
grew P. mendocina. An antibiotic resistance profile
was performed by a VITEK® analyzer (bioMérieux,
France). The antibiotic susceptibilities of the P.
mendocina isolate from our patient are summarized
in Table 1. His antimicrobial therapy was modified to
monotherapy with intravenous piperacillin-tazobactam
in order to cover both P. mendocina and anaerobes
in the leg ulcers due to putrid discharge and odor.
On day 3 of hospitalization, a dermatology consult
was requested for skin ulcer biopsy and culture to
identify the source of P. mendocina septicemia. Two
skin punch biopsies of his leg ulcers were obtained.
His leg wounds were then debrided and dressed by
our plastic surgery team.
Cultures of these skin biopsies grew Stenotrophomonas
maltophilia, but failed to isolate P. mendocina which
may be secondary to the prior antibiotic therapy.
Stenotrophomonas maltophilia was susceptible to
trimethoprim-sulfamethoxazole and resistant to ceftazi-
dime. Trimethoprim-sulfamethoxazole was added to his
antibiotic regimen. Histopathology of his skin biopsy
reported nonspecific acanthotic spongiotic parakeratosis
with mixed lymphocytes and neutrophil infiltrates. The
Fig. 1 Two large ulcerated wounds on the patient’s legs
Fig. 2 Two large ulcerated wounds on the patient’s legs
Table 1 Antibiotic susceptibility profile of Pseudomonas mendocina
isolated from our patient
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special stains of the skin tissues were negative for myco-
bacteria and fungi. The mycobacteria and fungal cultures
of the biopsied cutaneous tissues remained negative for 8
weeks. A literature review showed there is an association
of P. mendocina septicemia with infective endocarditis.
Given a new cardiac murmur, a transesophageal echocar-
diogram was performed. The echocardiogram demon-
strated two small mobile echo-densities (<1 cm) attached
to his anterior mitral valve leaflet, suggestive of vegeta-
tions, with mild mitral regurgitation (Fig. 3). A diagnosis
of P. mendocina native mitral valve infective endocarditis
was made. Our cardiothoracic surgery team was consulted
and recommended medical therapy given the small vege-
tations with trivial valvular insufficiency. Intravenous
piperacillin-tazobactam therapy was continued, and he
was discharged to a nursing facility to complete a 6-week
course of antibiotic therapy. He returned for a 1-month
follow-up and he had clinically improved and was able to
ambulate with minimal assistance.
Discussion
The genus Pseudomonas comprises at least 140 species
[4]. Among them, Pseudomonas aeruginosa possesses an
abundance of virulence factors and is regarded as the
most important pathogen responsible for serious life-
threatening infections in humans [4]. P. mendocina, a
non-aeruginosa Pseudomonas species, rarely causes
human infection.
P. mendocina, like other Pseudomonas species, is com-
monly found in soil, water, plants, and animals. A com-
prehensive review of the literature was performed by
searching PubMed® and Google Scholar® using the terms
“Pseudomonas mendocina infection” and “Pseudomonas
mendocina endocarditis”. As shown in Table 2, the case
reported here is the ninth reported case of human P.
mendocina infection, but the first reported case in the
USA [3, 5–11]. One case report was published in French
and is included in this review [8]. All eight published
cases are outside North America: three cases from Asia
(Taiwan, Singapore), two cases from Europe (Denmark,
France), two from the Middle East (Turkey, Israel), and
one from Argentina. Of the eight reported cases, five
were bacteremic [3, 5, 7–9]. The remaining three cases
were non-bacteremic, and associated with bone and soft
tissue infections [6, 10, 11]. Among the five patients with
P. mendocina bacteremia, four cases (80 %) involved
infective endocarditis [3, 5, 7, 8]. The affected cardiac
valves were native in all four cases of infective endocar-
ditis. The affected heart valves were predominantly left--
sided. Valvular repair or replacement was required in
two cases. The mechanism of predilection of valvular
endocarditis by this pathogen is obscure. No mortality
associated with the P. mendocina infection was reported.
The source of P. mendocina infection was not identi-
fied in most reported cases. Nseir and colleague’s specu-
lation on the source of infection is fascinating [9]. They
found that the patient had a peculiar habit of allowing a
bird to drink water from his mouth. P. mendocina was
isolated both from the tap water and the bird’s drinking
water. In our case, our patient had already received
intravenous antibiotics for 3 days when his leg wound
cultures were obtained. His skin tissue cultures failed
to grow P. mendocina because of the inhibitory effect
of antibiotics on the bacterial growth. Thus, we pos-
tulated that the leg wound ulcers were the likely
nidus of the infection.
Fig. 3 Transesophageal echocardiogram showed two vegetations on the patient’s mitral valve. Red arrows point to the vegetations
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Table 2 Published reports of Pseudomonas mendocina infection
Reference Age (in years)/
Gender
Country Past medical history Presenting complaint Specimen site Final diagnosis Treatment Valvular surgery Outcome
Aragone et al.,
1992 [3]
63/M Argentina Poliomyelitis, diabetes
mellitus, aortic valve
replacement, pacemaker
Fever and chills Blood Native mitral valve
endocarditis
IV ceftriaxone + IV gentamicin













Blood Native tricuspid valve
endocarditis
IV gentamicin + IV penicillin,
then IV gentamicin + IV ampicillin,






65/M Taiwan Alcoholism, renal
disease
Lower back pain Deep spinal
tissue
L4–L5 Spondylodiscitis IV cefepime × 2 weeks, followed




36/M Turkey Mental retardation Weight loss
and fever
Blood Native mitral valve
endocarditis







79/F France Atrial fibrillation,
transient ischemic
attack, hypertension
Fever Blood Native aortic valve
endocarditis





31/M Israel Nil Fever and chills Blood Bacteremia (no vegetation
on transthoracic
echocardiogram)
IV gentamicin × 4 days + po








Femur osteomyelitis Not mentioned NA Survived
Chiu and Wang,
2013 [11]
34/M Singapore Nil Motorcycle
accident
Foot tissue Foot wound infection
(polymicrobial pathogens)
IV cefazolin + IV gentamicin,
then po ciprofloxacin × 2 weeks,
followed by po trimethoprim-
sulfamethoxazole × 16 days
NA Survived
Current Report 57/M USA Gout, alcoholism Leg ulcers Blood Native mitral valve
endocarditis
IV piperacillin-tazobactam × 6
weeks
Not performed Survived











Because P. mendocina is not a common human patho-
gen, little knowledge exists about the antimicrobial
resistance patterns of this organism. This pathogen was
reportedly susceptible to ampicillin in some reported
cases [5, 7]. However, ampicillin or ampicillin-sulbactam
is not tested in the antibiotic susceptibility of non-
aeruginosa Pseudomonas species by the US Clinical and
Laboratory Standards Institute (CLSI) [12]. The third-
generation cephalosporins (cefotaxime, ceftriaxone,
cefoperazone, ceftizoxime) are included in the susceptibility
testing and recommended as a treatment of choice if
susceptible [4, 12]. Other traditional “anti-Pseudomonas
aeruginosa” antibiotics, including ceftazidime, cefepime,
piperacillin-tazobactam, aminoglycosides, carbapenems,
and ciprofloxacin, show an excellent activity against most
strains of P. mendocina [4, 12]. In one case report, Mert et
al. reported that their isolate of P. mendocina was suscep-
tible to all tested antibiotics (ampicillin, ceftazidime,
cefepime, piperacillin-tazobactam, imipenem, and gentami-
cin) [7]. Aragone et al. found ampicillin and cephalothin
resistance in their isolate [3]. Resistance to ampicillin and
ampicillin-sulbactam was demonstrated in the isolates from
a foot wound by Chiu and Wang [11]. In a case of spondy-
lodiscitis, the isolated P. mendocina pathogen from deep
spinal tissue was only resistant to trimethoprim-
sulfamethoxazole [6]. Nseir et al. identified ceftriaxone and
aztreonam resistance in their isolate [9]. The other cases in
Table 2 failed to report antibiotic resistances of their P.
mendocina isolate. The present isolate in our patient was
resistant to ampicillin-sulbactam and first-generation ceph-
alosporins. While these isolates indicate a low level of
antibiotic resistance in this organism, the minimal numbers
of cases preclude an in-depth analysis of antibiotic resist-
ance trends in this organism.
Conclusions
In summary, there were only eight cases of P. mendocina
human infections reported in the literature. Thus, there
is a limitation to draw major conclusions from these
cases. The actual incidence of P. mendocina infection is
likely to be underestimated as well as underreported. All
patients with P. mendocina infection survived. Most
cases were noticeably associated with native valve infect-
ive endocarditis. The preponderance of P. mendocina for
causing endocarditis warrants a discussion of echocardi-
ography for patients with P. mendocina septicemia. Fur-
ther research and clinical studies are required to identify
the underlying mechanism and pathogenicity of this
association. Although it is a relatively susceptible pathogen,
we would not advocate using ampicillin, ampicillin-sulbac-
tam, or the first- and second-generation cephalosporins as
first-line therapy in a serious infection even if reported to
be susceptible. The third-generation cephalosporins are
acceptable and recommended in the treatment of P.
mendocina infection. Guidance from antimicrobial sus-
ceptibility profiles in accordance with CLSI standards is
always helpful for the optimal therapy with favorable clin-
ical outcome.
Acknowledgements
We, the authors, would like to extend our thanks to all the medical and
surgical teams who participated in our patient’s care.
Authors’ contributions
GR, JM, and ZM participated in the patient’s care, literature search, and
manuscript drafting. NB and ZM were involved in a comprehensive literature
review and editorial review of the manuscript. All authors read and approved
the final version of the manuscript.
Competing interests
Dr Bhanot received an honorarium from the Speaker’s Bureau of Astellas and
he reviewed an article for the Postgraduate Institute for Medicine, USA. All
other authors declare no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of
this case report and accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
Author details
1Temple University School of Medicine, Philadelphia, PA, USA. 2Division of
Infectious Disease, Allegheny General Hospital, Allegheny Health Network,
420 East North Avenue, South Tower, East Wing, Suite 407, Pittsburgh, PA
15212, USA.
Received: 15 March 2016 Accepted: 7 September 2016
References
1. Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective
endocarditis in the U.S., 1998–2009: a nationwide study. PLoS One.
2013;8(3):e60033.
2. Palleroni NJ, Doudoroff M, Stanier RY. Taxonomy of the aerobic pseudomonas:
the properties of the Pseudomonas stutzeri group. J Gen Microbiol.
1970;60:215–31.
3. Aragone MR, Maurizi DM, Clara LO, Navarro Estrada JL, Ascione A.
Pseudomonas mendocina, an environmental bacterium isolated from
a patient with human infective endocarditis. J Clin Microbiol. 1992;30:1583–4.
4. D’Agata E. Pseudomonas aeruginosa and other Pseudomonas species. In:
Bennett J, Dolin R, Blaser M, editors. Mandell, Douglas, and Bennett’s
principles and practice of infectious diseases. 8th ed. Philadelphia:
Saunders; 2015. p. 2518–31.
5. Johansen HK, Kjeldsen K, Heiby N. Pseudomonas mendocina as a cause of
chronic infective endocarditis in a patient with situs inversus. Clin Microbiol
Infect. 2001;7:650–2.
6. Chi CY, Lai CH, Fung CP, Wang JH. Pseudomonas mendocina
spondylodiscitis: A case report and literature review. Scand J Infect Dis.
2005;37:951–3.
7. Mert A, Yilmaz M, Ozaras R, Kocak F, Dagsali S. Native valve endocarditis due
to Pseudomonas mendocina in a patient with mental retardation and a
review of the literature. Scand J Infect Dis. 2007;39:615–6.
8. Suel P, Martin P, Berthelot G, Robaday S, Etienne M, Chibani A. A case of
Pseudomonas mendocina endocarditis. Med Mal Infect. 2011;41:109–10.
9. Nseir W, Hussein T, Abid A, Khateeb J. Pseudomonas mendocina sepsis in a
healthy man. Isr Med Assoc J. 2011;13:375–6.
10. Howe TS, Erlich G, Koh JSB, Ng ACM, Costerton W. A case of an atypical
femoral fracture associated with bacterial biofilm-pathogen or bystander?
Osteoporos Int. 2013;24:1765–6.
11. Chiu LQ, Wang W. A case of unusual Gram-negative bacilli septic arthritis in
an immunocompetent patient. Singapore Med J. 2013;54(8):e164–8.
12. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for
Antimicrobial Susceptibility Testing. Twenty-Fifth Informational Supplement.
CLSI document M100-S25. Wayne: CLSI; 2015. p. 62–3.
Rapsinski et al. Journal of Medical Case Reports  (2016) 10:275 Page 5 of 5
